Wave (WVE) Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Globe and Mail, The
Chief Medical Officer — Chris Wright President, Research and Development — Erik Ingelsson Chief Financial Officer — Kyle B. Moran Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Revenue -- $8.7 million, a decrease from $19.7 million, attributed to the timing of revenue recognition under the GSK collaboration. Research and Development Expenses -- $43.5 million, up from $40.4 million, primarily due to increased investment in the INHBE and RNA editing programs plus higher compensation-related costs. General and Administrative Expenses -- $18 million versus $14.3 million, influenced by share-based compensation and external spend. Net Loss -- $50.5 million, widening from $32.9 million, driven by increased operating expenses and reduced revenue. Cash and Cash Equivalents -- $208.5 million at period end, down from $302.1 million at the prior year-end; management expects this to fund operations into 2027, not factoring potential milestones from GSK. A
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave (WVE) Q1 2026 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- WAVE Life Sciences (WVE) was given a new $15.00 price target by Truist Financial Corporation.MarketBeat
- Wave (WVE) Q1 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- WAVE Life Sciences Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 4/28/26 - Beat
WVE
Sec Filings
- 4/28/26 - Form 10-Q
- 4/28/26 - Form 8-K
- 4/21/26 - Form DEFA14A
- WVE's page on the SEC website